State of Alaska Department of Revenue Sells 2,010 Shares of Danaher Co. (NYSE:DHR)

State of Alaska Department of Revenue lessened its stake in shares of Danaher Co. (NYSE:DHR) by 2.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 73,287 shares of the conglomerate’s stock after selling 2,010 shares during the quarter. State of Alaska Department of Revenue’s holdings in Danaher were worth $16,823,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Heck Capital Advisors LLC purchased a new position in Danaher in the fourth quarter valued at about $27,000. Decker Retirement Planning Inc. bought a new stake in shares of Danaher in the 4th quarter valued at about $31,000. Teachers Insurance & Annuity Association of America purchased a new position in shares of Danaher in the 3rd quarter worth approximately $39,000. MidAtlantic Capital Management Inc. bought a new position in shares of Danaher during the 3rd quarter worth approximately $40,000. Finally, FSA Wealth Management LLC acquired a new stake in Danaher in the third quarter valued at approximately $50,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 10.90% of the stock is owned by corporate insiders.

Danaher Trading Down 1.4 %

Shares of NYSE:DHR opened at $211.92 on Thursday. The company has a market capitalization of $153.07 billion, a PE ratio of 40.14, a PEG ratio of 2.80 and a beta of 0.83. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The business has a 50 day moving average of $234.50 and a two-hundred day moving average of $252.68. Danaher Co. has a 12-month low of $210.04 and a 12-month high of $281.70.

Danaher (NYSE:DHR) last posted its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the company posted $2.09 EPS. As a group, analysts forecast that Danaher Co. will post 7.77 EPS for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were given a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.51%. Danaher’s dividend payout ratio (DPR) is 20.45%.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on DHR shares. StockNews.com downgraded Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. JPMorgan Chase & Co. reduced their target price on Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Robert W. Baird dropped their price target on Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $277.00 price objective (down from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Finally, Guggenheim started coverage on shares of Danaher in a research report on Thursday, December 19th. They set a “buy” rating and a $275.00 target price on the stock. Seven analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.